| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.48M | 289.72M | 250.32M | 208.89M | 193.91M | 203.94M |
| Gross Profit | 207.99M | 172.11M | 156.07M | 179.29M | 186.05M | 170.63M |
| EBITDA | 78.28M | 69.33M | 57.80M | 81.16M | 91.00M | 78.91M |
| Net Income | 57.27M | 53.00M | 43.38M | 61.44M | 69.01M | 59.49M |
Balance Sheet | ||||||
| Total Assets | 6.98B | 5.81B | 5.71B | 5.67B | 5.50B | 4.90B |
| Cash, Cash Equivalents and Short-Term Investments | 988.61M | 792.76M | 725.61M | 771.30M | 1.73B | 1.26B |
| Total Debt | 748.49M | 544.95M | 529.94M | 309.51M | 255.94M | 246.77M |
| Total Liabilities | 6.31B | 5.27B | 5.22B | 5.22B | 4.96B | 4.37B |
| Stockholders Equity | 676.44M | 531.23M | 495.06M | 451.28M | 541.29M | 529.31M |
Cash Flow | ||||||
| Free Cash Flow | 80.38M | 55.36M | 64.89M | 103.00M | 140.86M | 15.30M |
| Operating Cash Flow | 86.35M | 60.93M | 67.51M | 105.18M | 142.72M | 18.23M |
| Investing Cash Flow | -76.80M | 30.33M | -7.03M | -487.72M | -649.09M | -294.45M |
| Financing Cash Flow | -50.22M | 23.90M | -36.10M | 237.34M | 581.23M | 346.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $703.13M | 9.55 | 13.43% | 2.93% | 47.65% | 101.00% | |
78 Outperform | $761.48M | 17.71 | 6.26% | 4.16% | 8.23% | -0.07% | |
78 Outperform | $683.25M | 10.15 | 14.51% | 3.09% | 4.29% | 10.56% | |
74 Outperform | $784.43M | 10.51 | 15.62% | 3.55% | -0.23% | 10.95% | |
72 Outperform | $760.32M | 12.81 | 9.49% | 3.66% | 24.08% | 9.83% | |
72 Outperform | $728.83M | 12.99 | 7.31% | 2.58% | 12.09% | -15.97% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On January 8, 2026, Camden National Corporation announced that its board of directors had authorized a new share repurchase program for up to 850,000 shares of its common stock, representing about 5% of its issued and outstanding shares as of December 31, 2025, with the program becoming effective on January 7, 2026. The repurchases, which may be conducted via open market purchases, accelerated share repurchase transactions, or privately negotiated deals under Rule 10b5-1 plans, are designed to provide the company with flexible capital management options and can be adjusted or suspended depending on market conditions, the company’s capital position, and internal capital generation, potentially affecting share liquidity and shareholder value.
The most recent analyst rating on (CAC) stock is a Buy with a $53.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.
On December 16, 2025, Camden National Corporation announced a quarterly dividend of $0.42 per share, resulting in an annualized yield of 3.68% based on the December 15, 2025 stock price. The dividend is set to be paid on January 30, 2026, to shareholders recorded by January 15, 2026, reflecting the company’s ongoing commitment to returning value to its investors.
The most recent analyst rating on (CAC) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.
Camden National Corporation recently completed the acquisition of Northway Financial, which closed on January 2, 2025, with systems conversion in March 2025. This strategic move is expected to bolster Camden National’s presence in Northern New England, with anticipated cost savings and earnings per share accretion. The company is also focusing on digital innovation, with significant increases in digital account origination and customer engagement, enhancing operational efficiency and customer service through AI-driven solutions.
The most recent analyst rating on (CAC) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.
Camden National Corporation recently completed the acquisition of Northway Financial, which was finalized on January 2, 2025, with systems conversion in March 2025. The acquisition is expected to enhance Camden National’s presence in Northern New England, with significant cost savings and increased earnings per share anticipated. The company’s strategic objectives include expanding commercial banking, bolstering wealth management, and leveraging digital innovations to drive growth and operational excellence.
The most recent analyst rating on (CAC) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.